BioLife Solutions Executives Sell Shares
Okuma süresi: 1 dakikadan kısa
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Mathew Aby J. | EVP & Chief Scientific Officer | Sell | $11,936 | Form 4 |
| Wichterman Troy | Chief Financial Officer | Sell | $19,530 | Form 4 |
Mathew Aby J., EVP & Chief Scientific Officer at BioLife Solutions, sold 536 shares of Common Stock on July 7, 2025, at a price of $22.27 per share, totaling $11,936. Following the transaction, Aby directly owns 352,582 shares of the company. The sale was conducted under a Rule 10b5-1(c) trading plan for tax obligations related to restricted stock vesting.
Troy Wichterman, Chief Financial Officer of BioLife Solutions, sold 877 shares of Common Stock on July 7, 2025, at a price of $22.27 per share, totaling $19,530. Following the transaction, Wichterman directly owns 185,808 shares of the company. The sale was conducted under a Rule 10b5-1(c) trading plan adopted on January 3, 2023.